Bifidobacterium longum NCC3001

Bifidobacterium longum NCC3001 · Société des Produits Nestlé (SPN)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bifidobacterium longum NCC3001, covering 2025-02-28 to 2025-02-28. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome [NA]

See pricing